Focus Stock of the Week: Take-Two Interactive Software, Inc.

SP Capital IQ  |

S&P Capital IQ Equity Analyst Jim Yin has a 5-STARS "Strong Buy" recommendation for Take-Two Interactive Software, Inc. (TTWO) . For more information, please visit: www.marketscope.com.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
TTWO Take-Two Interactive Software Inc. 126.87 -5.19 -3.93 2,414,493 Trade
NRBT Novus Robotics Inc 0.14 0.00 0.35 150

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.